LYON, France, March 20, 2017 /PRNewswire/ -- Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) and Mapi Language Services, the most trusted provider of linguistic validation, have partnered with Dr Isabelle Gélinas, the author of the Disability Assessment for Dementia (DAD) to be the exclusive licensor, distributor and translator of the DAD and all its derivatives including translations and electronic versions.
The DAD, a 40-item questionnaire originally published by Dr Gélinas and Professor Gauthier in 1999, has since then become a reference instrument to quantitatively measure functional abilities in activities of daily living (ADL) in individuals with cognitive impairments such as dementia. "Collaborating with Mapi will assure the production of high quality and harmonized translations and electronic versions of the DAD and their dissemination within the scientific community, while respecting the integrity and copyright of my questionnaire," said Isabelle Gélinas.
"The consistency across translations and between paper and electronic versions is essential to ensure the integrity of COAs and the accuracy of the results they gather," said Katrin Conway, Managing Director of the Mapi Research Trust. "Selecting Mapi, the most trusted name in COA and Medical Translation, as the exclusive provider ensures that the research and clinical use of the DAD meet the high standards that the author and the scientific community demand," commented Ana Bayles, Global Director– Language Services.
Mapi Research Trust provides unique assistance and services to questionnaire developers by centralizing and enabling access of their instruments and derivatives to all potential users. "Mapi Language Services has already produced over 60 translations of the DAD which will be available through our online ePROVIDE platform (https://eprovide.mapi-trust.org/)," added Conway. Of note, the DAD will also be at the heart of a Panel Session titled "Validly and Reliably Measuring Functional Performance in Dementia Patients Across Countries and Languages in Clinical Trials" at the next Annual American Society for Clinical Psychopharmacology (ASCP) Meeting held May 29 – June 2, 2017 in Miami, Florida.
For any request about the DAD or to view the DAD's description, please consult https://eprovide.mapi-trust.org/
About Mapi Language Services:
Mapi Language Services is the worldwide leader in medical translation and Linguistic Validation of COAs for more than 25 years. Mapi has first-hand knowledge of local languages and cultures, regulations, and healthcare practices. We work in close collaboration with developers, assure conceptual equivalence and international harmonization of all language versions. Mapi Language Services' experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages.
Visit https://www.mapigroup.com for more information.
About Mapi Research Trust:
Mapi Research Trust is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 280 exclusive questionnaires. As the worldwide leader in translation and linguistic validation of COAs for more than 25 years, Mapi's experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages. Visit http://mapi-trust.org/ for more information
About Dr Isabelle Gélinas:
Dr Gélinas is Associate Professor, Graduate Program Director and Director of the Graduate Certificate Programs at McGill University School of Physical and Occupational Therapy in Montreal, Canada. Dr Gélinas' research focuses on the activities and the contextual factors (personal and environmental) that shape the level of social participation of adults and elderly with disability. More specifically, her research encompasses two main domains: Driving rehabilitation and Activities of Daily Living. Presently her research projects are directed at: 1) the assessment and training of driving abilities in seniors and in clients with disabilities, 2) the development of daily living assessment in persons with disabling conditions, 3) the development and the evaluation of intervention strategies to improve the participation and social inclusion of persons with a disability
Press contact: Media@mapigroup.com
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/mapi-research-trust-selected-as-exclusive-distributor-and-mapi-language-services-selected-as-exclusive-translator-of-the-disability-assessment-for-dementia-dad-300425478.html
SOURCE Mapi Research Trust